Discover 680 paid clinical trials in Killeen, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 680
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
for
Colo-rectal Cancer
Location: Austin TX
Sponsor: Natera, Inc.
Sex: All
Age: 40+
Code: NCT07046585
Recruiting
C-Brace Prospective Registry
for
Pareses, Lower Extremity
Location: Austin TX, Fort Worth TX, Dallas TX, Saint Louis MO,
Sponsor: Otto Bock Healthcare Products GmbH
Sex: All
Age: 0+
Code: NCT04640584
Recruiting
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
for
Solid Tumors
Location: Austin TX, Houston TX, Minneapolis MN,
Sponsor: Adcentrx Therapeutics
Sex: All
Age: 18+
Code: NCT06710379
Phase1, Recruiting
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumor
Location: Austin TX, Fort Worth TX, Grand Rapids MI, Houston TX,
Sponsor: Pliant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06270706
Phase1, Recruiting
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Austin TX, Irving TX, Houston TX, New York NY,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06167317
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Austin TX, San Antonio TX, Irving TX, Ogden UT,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06804824
Phase1, Recruiting
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Location: Austin TX, San Antonio TX, Irving TX, Fairfax VA
Sponsor: OncoResponse, Inc.
Sex: All
Age: 18+
Code: NCT06090266
Phase1, Phase2, Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Austin TX, Plano TX, Oklahoma City OK, Atlanta GA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 0+
Code: NCT06480383
Phase2, Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Effects of Microprocessor-controlled Prosthetic Knees on Fall-related Health Outcomes in Limited Community Ambulators
for
Amputation, Prosthesis User,
Location: Austin TX
Sponsor: Hanger Institute for Clinical Research and Education, LLC
Sex: All
Age: 18+
Code: NCT06937242
Recruiting
Comparing the Attentional Demands and Functional Outcomes in People With Transradial Amputation
for
Amputation, Prosthesis Use
Location: Austin TX, Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 18+
Code: NCT07075042
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Austin TX, San Antonio TX, Dallas TX, Frisco TX,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
for
Post Procedural Erythema
Location: Austin TX, Dallas TX, Tyler TX, Scottsdale AZ,
Sponsor: Acorn Biolabs Inc.
Sex: All
Age: 18+
Code: NCT06477172
Recruiting
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
for
Solid Tumor
Location: Austin TX, San Antonio TX, Irving TX, Houston TX,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06874335
Phase1, Recruiting
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Austin TX, San Antonio TX, Houston TX, Oklahoma City OK,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05932862
Phase1, Recruiting
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)